Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas)

Sep-13

AUTHORS : Prof Gary Collins, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK – Email: gary.collins@csm.ox.ac.uk – Profile: https://www.ndorms.ox.ac.uk/team/gary-collins – Director of Equador Centre UK: https://www.ndorms.ox.ac.uk/research/research-groups/equator-network

JOURNAL : British Journal of General Practice

REFERENCE: 63(614):e636-42

DOI : 10.3399/bjgp13X671623

Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas)

More publications

Evaluating the potential impact of lifestyle‑based behavior change interventions delivered at the time of colorectal cancer screening

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions

Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin